At Clarian Neuroscience, we link knowledge, compassion and the latest technologies to provide a comprehensive scope of neurological services. We treat disorders of the nervous system, including the brain, spinal cord, nerves and muscles.

The Clarian program, which includes both Methodist Hospital and Indiana University Hospital, is one of the largest neuroscience programs in the country and in 2008 was ranked 24th in the United States by U.S.News and World Report. Clarian Neuroscience houses a neuro intensive care unit made up of a 34-bed neuro unit, an eight-bed stroke unit, a four-bed progressive care unit and the largest neuro critical care unit in the country on the campus of Methodist Hospital.

Clarian Neuroscience offers Indiana's most comprehensive neurology program that specializes in Alzheimer's disease and other dementias; infectious diseases of the central nervous system; movement disorders, including Parkinson's disease, essential tremor and dystonia; neuroimmunology and multiple sclerosis; neuromuscular diseases and neuro-oncology. The epilepsy program is Indiana's only program to be designated as a level 4 specialized epilepsy center by the National Association of Epilepsy Centers. It offers monitoring units at three Clarian Health hospitals.

In addition, Clarian Neuroscience has been designated as a primary stroke center by the Joint Commission. The Joint Commission's Certificate of Distinction for Primary Stroke Centers recognizes medical facilities that make exceptional efforts to improve care for stroke patients. The designation demonstrates Clarian’s commitment to the highest level of stroke care, indicating it has the resources necessary to quickly meet the specialized needs of patients who suffer a stroke. For more information on stroke prevention and treatment, visit ACallToChange.org.

Clarian is proud to be a partner with the Midwest Proton Radiotherapy Institute in Bloomington, Indiana. Only five such proton therapy centers exist in the United States. These centers offer patients suffering from brain tumors, other neurological conditions and many other types of cancer pinpoint accuracy in precisely targeting a tumor.